Napsin A expression in lung and kidney neoplasia: a review and update
- PMID: 22156835
- DOI: 10.1097/PAP.0b013e31823e472e
Napsin A expression in lung and kidney neoplasia: a review and update
Abstract
Napsin A is an aspartic protease present in the epithelial cells of the lung and kidney. Recent studies have shown that, in lung tumors, napsin A expression is restricted to lung adenocarcinomas, whereas among renal tumors, it is frequently expressed in renal cell carcinomas, especially the papillary and clear cell subtypes. Owing to its restricted expression, napsin A is a useful marker that can assist in the diagnosis of both lung adenocarcinomas and renal cell carcinomas.
Similar articles
-
Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.Hum Pathol. 2010 Jan;41(1):20-5. doi: 10.1016/j.humpath.2009.06.014. Epub 2009 Sep 8. Hum Pathol. 2010. PMID: 19740516
-
Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions.Diagn Cytopathol. 2007 Aug;35(8):493-7. doi: 10.1002/dc.20667. Diagn Cytopathol. 2007. PMID: 17636482
-
Napsin A is a useful marker for metastatic adenocarcinomas of pulmonary origin.Histopathology. 2014 Aug;65(2):195-206. doi: 10.1111/his.12383. Epub 2014 Mar 26. Histopathology. 2014. PMID: 24479710
-
Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma.Cancer Biomark. 2010;7(6):261-8. doi: 10.3233/CBM-2010-0195. Cancer Biomark. 2010. PMID: 21694464 Review.
-
The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms.Clin Lab Med. 2005 Jun;25(2):247-57. doi: 10.1016/j.cll.2005.01.004. Clin Lab Med. 2005. PMID: 15848735 Review.
Cited by
-
A target safety assessment of the potential toxicological risks of targeting plasmepsin IX/X for the treatment of malaria.Toxicol Res (Camb). 2021 Feb 15;10(2):203-213. doi: 10.1093/toxres/tfaa106. eCollection 2021 Mar. Toxicol Res (Camb). 2021. PMID: 33884171 Free PMC article. Review.
-
Tumor-to-tumor metastasis from lung cancer: a clinicopathological postmortem study.Virchows Arch. 2013 Oct;463(4):525-34. doi: 10.1007/s00428-013-1455-8. Epub 2013 Aug 3. Virchows Arch. 2013. PMID: 23913165
-
The expression of TTF-1 and Napsin A in early-stage lung adenocarcinoma correlates with the results of surgical treatment.Tumour Biol. 2015 Sep;36(10):8085-92. doi: 10.1007/s13277-015-3478-z. Epub 2015 May 16. Tumour Biol. 2015. PMID: 25982999
-
T-cell tolerant fraction as a predictor of immune-related adverse events.J Immunother Cancer. 2023 Aug;11(8):e006437. doi: 10.1136/jitc-2022-006437. J Immunother Cancer. 2023. PMID: 37580069 Free PMC article.
-
Napsin A Expression in Human Tumors and Normal Tissues.Pathol Oncol Res. 2021 Apr 20;27:613099. doi: 10.3389/pore.2021.613099. eCollection 2021. Pathol Oncol Res. 2021. PMID: 34257582 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases